Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival.

The CR rates with tagraxofusp vs other treatments were numerically lower in those with skin disease (30% vs 83%; P = .12) and in those with systemic disease (41% vs 71%; P = .063), but these results did not reach statistical significance.

also in 111,027 other papers